我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Molecular Docking and Drug Repurposing Finding New Uses for Old Drugs

Raadan Konnai

This article explores the fascinating intersection of molecular docking and drug repurposing, showcasing how old drugs can find new life in alternative therapeutic applications. Drug repurposing, or repositioning, is gaining momentum as a cost-effective and time-efficient strategy to discover novel medical treatments. Molecular docking, a computational technique, plays a pivotal role in this process by enabling the study of ligand-receptor interactions and predicting binding affinities. Case studies highlight successful drug repurposing initiatives, emphasizing the role of molecular docking in uncovering these new applications. Challenges and prospects in the field are also discussed, underscoring the ongoing synergy between computational techniques and experimental validation. As the pharmaceutical industry evolves, the synergy between molecular docking and drug repurposing promises to expedite innovative therapy development, benefiting patients and reducing costs

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。